文献速递心脏核医学

CZT-SPECT测量心肌血流储备的预后价值

Prognostic impact of myocardial flow reserve assessed by cadmium-zinc-telluride single-photon emission computed tomography.
PubMed 文献 · J Nucl Cardiol · 2026-06-09

该回顾性研究纳入452例接受一日法静息/负荷99mTc-甲氧基异丁基异腈动态CZT-SPECT心肌血流储备(MFR)定量的连续患者,中位随访792天,发现MFR<2与总事件和主要不良心血管事件风险显著升高相关,且MFR在临床危险因素和相对灌注显像之外提供增量预后价值。

要点

  • MFR<2与总事件风险升高相关(HR 3.8,95%CI 2.5-5.7,P<0.001)。
  • MFR<2与主要不良心血管事件风险升高相关(HR 7.9,95%CI 3.5-17.6,P<0.001)。
  • 加入MFR后预测性能提升,总事件C指数从0.63升至0.77,MACE从0.76升至0.84。

核心结论

  • CZT-SPECT测量的MFR<2可显著预测包括死亡在内的不良心血管结局,并在临床危险因素和相对灌注显像之外提供增量预后价值。

研究设计与样本

  • 回顾性分析452例连续患者,均接受一日法静息/负荷99mTc-甲氧基异丁基异腈动态CZT-SPECT进行MFR定量,中位随访792天。

主要发现

  • 452例患者平均年龄63±12岁,54%为男性,190例(42%)MFR<2。
  • 随访期间共发生190例总事件和63例主要事件,全部7例死亡均见于MFR降低组。
  • MFR<2与总事件风险升高相关(HR 3.8,95%CI 2.5-5.7,P<0.001)。
  • MFR<2与主要事件风险升高相关(HR 7.9,95%CI 3.5-17.6,P<0.001)。
  • 加入MFR后预测性能改善,总事件C指数从0.63升至0.77,MACE从0.76升至0.84(均P<0.001)。

关键数值与推荐

  • MFR计算为负荷与静息心肌血流比值,MFR<2定义为异常。
  • 主要不良心血管事件(MACE)定义为死亡、心肌梗死、血运重建或卒中。

临床怎么用

  • 常规纳入CZT-SPECT的MFR评估可能改善风险分层,并指导慢性冠脉综合征的个体化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial flow reserve (MFR) reflects the ability of the coronary circulation to augment blood flow in response to increased demand, integrating both epicardial and microvascular function. Although its prognostic value has been demonstrated with invasive techniques and positron emission tomography (PET), evidence using cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) remains limited. The aim of this study was to evaluate the prognostic impact of MFR assessed by CZT-SPECT in patients with and without obstructive coronary artery disease (CAD). METHODS: We retrospectively analyzed 452 consecutive patients who underwent one-day rest/stress ˆ99mTc-sestamibi dynamic CZT-SPECT for MFR quantification. MFR was calculated as the ratio of stress to rest myocardial blood flow, with values <2 considered abnormal. Median follow-up was 792 days. Follow-up was censored at the last documented clinical visit for patients without events. Adverse cardiovascular events included angina, myocardial infarction, stroke, revascularization, hospitalization for angina or heart failure, and death. Major adverse cardiovascular events (MACE) were defined as death, myocardial infarction, revascularization, or stroke. Kaplan-Meier survival curves and Cox proportional hazard models were used, and incremental prognostic value was assessed with the C-index and likelihood ratio tests. RESULTS: Among 452 patients (mean age: 63 ± 12 years, 54% male), 190 (42%) had MFR <2. During follow-up, 190 total events and 63 major events occurred. All deaths (n = 7) were observed in the reduced MFR group. MFR <2 was significantly associated with a higher risk of total events (hazard ratio [HR]: 3.8, 95% confidence interval [CI]: 2.5-5.7; P < 0.001) and major events (HR: 7.9, 95% CI: 3.5-17.6; P < 0.001). Incorporating MFR improved predictive performance (C-index from 0.63 to 0.77 for total events and from 0.76 to 0.84 for MACE; both P < 0.001). CONCLUSIONS: MFR <2 assessed by CZT-SPECT significantly predicted adverse cardiovascular outcomes, including death, and provided incremental prognostic value beyond clinical risk factors and relative perfusion imaging. Routine incorporation of MFR assessment may improve risk stratification and guide personalized management of chronic coronary syndromes.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Carvelli MV, Masoli OH, Gobbo M, et al. Prognostic impact of myocardial flow reserve assessed by cadmium-zinc-telluride single-photon emission computed tomography. J Nucl Cardiol. 2026. PMID: 42263841. doi:10.1016/j.nuclcard.2026.102774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。